Product image of Mylotarg 5 mg (Gemtuzumab ozogamicin ) 5mg Vials supplied by GNH India

Mylotarg 5 mg

Active Ingredient:
Gemtuzumab ozogamicin
Form:
Vials
Brand:
Mylotarg
Origin:
USA

Mylotarg 5 mg (Gemtuzumab ozogamicin Vials) 5mg

MYLOTARG 5 MG (gemtuzumab ozogamicin) is an injectable prescription medication used in cancer treatment. This 5mg vial formulation is designed for intravenous administration under medical supervision. Store between 2-8°C to maintain potency and efficacy.

Strength

5mg

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

Pfizer

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • MYLOTARG 5 MG is used in the treatment of certain types of acute myeloid leukemia (AML), a cancer of the blood and bone marrow. It targets CD33-positive cancer cells, helping to reduce disease progression. This medication is typically administered by healthcare professionals in clinical settings. Patients often ask what MYLOTARG 5 MG is used for in cancer therapy.

Side Effects

  • As a targeted therapy, MYLOTARG 5 MG works by binding to cancer cells and delivering a cytotoxic agent to destroy them. Common effects include temporary reductions in blood cell counts, which may lead to increased infection risk or fatigue. Some patients may experience infusion-related reactions during administration.

Precautions & Warnings

  • MYLOTARG 5 MG should only be handled and administered by trained healthcare providers in a controlled medical environment. Patients must be monitored closely for signs of infection, bleeding, or infusion reactions. Keep vials refrigerated at 2-8°C and protect from light until ready for use. Do not use if the solution is discolored or contains particles.

Avoid Interactions

  • MYLOTARG 5 MG may interact with other medications that affect liver enzymes or bone marrow function. Concomitant use of strong CYP3A4 inhibitors or inducers could alter its metabolism. Live vaccines should be avoided during treatment due to potential immune system impacts. Always inform your healthcare provider about all medications and supplements being taken.

Frequently Asked Questions

MYLOTARG 5 MG is used to treat certain types of acute myeloid leukemia (AML) in adults and children.

It is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common effects include low blood cell counts, fever, nausea, and infusion-related reactions.

No, it must be refrigerated between 2-8°C and protected from light until use.

Yes, it is a targeted therapy used in cancer treatment, often classified alongside chemotherapy agents.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Gemtuzumab ozogamicin

Mylotarg 5 mg/5mL

Mylotarg 5 mg/5mL

5 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Mylotarg 4.5 mg

Mylotarg 4.5 mg

4.5 MG POWDER FOR SOLUTION
Mylotarg 5 mg

Mylotarg 5 mg

5mg Vials

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT